Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
20.0%
% of BBH's 27 holdings also in IBRN
11.9%
% of IBRN's 60 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 5.1% | 4.2% | 4.2% |
 |
BIOGEN IDEC INC | 3.4% | 3.9% | 3.4% |
|
INTRA-CELLULAR THERAPIES INC | 2.9% | 4.2% | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.2% | 4.2% | 2.2% |
|
SAREPTA THERAPEUTICS INC | 1.3% | 2.9% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IBRN
|
AMGEN INC | 16.1% |
|
GILEAD SCIENCES INC | 12.5% |
|
VERTEX PHARMACEUTICALS INC | 11.2% |
|
REGENERON PHARMACEUTICALS | 5.2% |
|
NATERA INC | 4.5% |
|
IQVIA HOLDINGS INC | 4.4% |
|
ALNYLAM PHARMACEUTICALS INC | 4.4% |
 |
ICON PLC | 3.6% |
|
ILLUMINA INC | 2.7% |
|
INSMED INC | 2.6% |
BBH Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -4.7% |
|
PTC THERAPEUTICS INC | -4.4% |
|
ACADIA PHARMACEUTICALS INC | -4.1% |
|
ALKERMES PLC | -4.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.9% |
|
DENALI THERAPEUTICS INC. | -3.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
EDGEWISE THERAPEUTICS, INC. | -3.3% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |